El-Sawy Tarek, Bakhoum Mathieu F, Tetzlaff Michael, Nasser Qasiem J, Prieto Victor G, Ivan Doina, Sniegowski Matthew C, Yin Vivian T, Pan Caroline, Durairaj Vikram, Esmaeli Bita
Orbital Oncology & Ophthalmic Plastic Surgery Program, Department of Plastic Surgery and.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Digit J Ophthalmol. 2014 Jul 14;20(3):35-40. doi: 10.5693/djo.01.2014.02.001. eCollection 2014.
To describe 3 cases of primary orbital melanoma associated with either known or subsequently discovered cellular blue nevus.
The clinical records and surgical specimens of 3 patients who underwent orbital exenteration for primary orbital melanoma and who had a cellular blue nevus diagnosed before or after detection of the melanoma were retrospectively reviewed.
All 3 patients presented with signs and symptoms of an orbital mass. Subsequent biopsy revealed invasive melanoma. One patient had a known history of congenital cellular blue nevus of the eyelid from which the orbital melanoma originated. The other 2 patients had no known history of cutaneous pigmentation or blue nevus. In these 2 patients, the cellular blue nevus was detected on pathologic review of the orbital exenteration specimen (1 patient) or surgical biopsy specimen (1 patient). All 3 patients underwent total body positron emission tomography/computed tomography, and in all 3 results were negative for other sites of disease involvement. In the 2 patients without a previously known nevus a total body skin check was negative for other primary melanoma lesions. All 3 patients underwent orbital exenteration followed by postoperative radiation therapy.
Thorough evaluation of biopsy specimens of "primary" orbital melanoma is warranted to ensure identification of any associated blue nevus because blue nevi are precursor lesions for orbital melanoma, and the presence of a blue nevus would support a primary orbital melanoma rather than a metastatic lesion. Patients with a known blue nevus of the periocular skin and ocular adnexa should be monitored closely for signs of malignant transformation.
描述3例与已知或随后发现的细胞性蓝痣相关的原发性眼眶黑色素瘤病例。
回顾性分析3例因原发性眼眶黑色素瘤接受眼眶内容物剜除术且在黑色素瘤发现之前或之后诊断出细胞性蓝痣的患者的临床记录和手术标本。
所有3例患者均表现为眼眶肿物的体征和症状。随后的活检显示为浸润性黑色素瘤。1例患者有已知的眼睑先天性细胞性蓝痣病史,眼眶黑色素瘤起源于此。另外2例患者无皮肤色素沉着或蓝痣病史。在这2例患者中,细胞性蓝痣在眼眶内容物剜除术标本(1例患者)或手术活检标本(1例患者)的病理检查中被发现。所有3例患者均接受了全身正电子发射断层扫描/计算机断层扫描,结果显示所有3例患者其他部位均无疾病累及。在2例既往无已知蓝痣的患者中,全身皮肤检查未发现其他原发性黑色素瘤病灶。所有3例患者均接受了眼眶内容物剜除术,随后进行了术后放射治疗。
对“原发性”眼眶黑色素瘤的活检标本进行全面评估,以确保识别任何相关的蓝痣,这是必要的,因为蓝痣是眼眶黑色素瘤的前驱病变,蓝痣的存在将支持原发性眼眶黑色素瘤而非转移性病变。对已知眶周皮肤和眼附属器有蓝痣的患者应密切监测恶变迹象。